Boiron SA (EPA: BOI)

Market Cap	460.10M
Revenue (ttm)	481.71M
Net Income (ttm)	23.69M
Shares Out	17.36M
EPS (ttm)	1.36
PE Ratio	19.42
Forward PE	23.38
Dividend	1.35 (5.09%)
Ex-Dividend Date	n/a

Volume	202
Open	27.00
Previous Close	26.85
Day's Range	26.50 - 27.00
52-Week Range	26.30 - 42.80
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,810
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2023, Boiron's revenue was 493.25 million, a decrease of -7.67% compared to the previous year's 534.24 million. Earnings were 35.83 million, a decrease of -19.80%.